USPTO Says Revival Of Fintiv Suit Doesn't Help AstraZeneca
The U.S. Patent and Trademark Office has argued that a recent court decision reviving Apple's lawsuit against the office does not support a separate challenge to a rule providing guidelines on...To view the full article, register now.
Already a subscriber? Click here to view full article